100
Participants
Start Date
January 24, 2023
Primary Completion Date
November 24, 2024
Study Completion Date
December 24, 2024
Infiltrative treatment with CB-PRP
Injection of CB-PRP or placebo into the vulvar site. Three treatments are planned four weeks apart. Three and six months after the last treatment with CB-PRP/ placebo each participant will be re-evaluated by vulvoscopy and biopsy, and will be given validated questionnaires to assess satisfaction, symptoms, and quality of life, psychological state, and sexual function.
RECRUITING
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER